Effect of vitamin D on prostate
Phase 4
Recruiting
- Conditions
- benign prostatic hyperplasia.Enlarged prostate
- Registration Number
- IRCT20180201038585N9
- Lead Sponsor
- Bagheiat-allah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 60
Inclusion Criteria
Suffered from BPH based on the diagnosis of a clinical specialist
Signing of a informed consent form
Exclusion Criteria
Allergy to vitamin D
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum levels of prostate-specific antigen (PSA). Timepoint: At the beginning of the study and 56 days after weekly intake of vitamin D. Method of measurement: Using a specific kit.
- Secondary Outcome Measures
Name Time Method Serum levels of vitamin d. Timepoint: At the beginning of the study and 56 days after the intervention. Method of measurement: with using specific kit.;Serum levels of calcium and phosphorus. Timepoint: At the beginning of the study and 56 days after the intervention. Method of measurement: with using specific kit.;Serum levels of testosterone and LH. Timepoint: At the beginning of the study and 56 days after the intervention. Method of measurement: with using specific kit.;Size of prostate. Timepoint: At the beginning of the study and 56 days after the intervention. Method of measurement: with using sonogrphy.;Clinical signs of prostate hyperplasia. Timepoint: At the beginning of the study and 56 days after the intervention. Method of measurement: Using a validated questionnaire.